Health

Parkinson’s Disease Medications

[ad_1]

The following prescription drugs increase the amount of dopamine in the brain. Guidelines from the American Academy of Neurology (AAN) aim to assist doctors in choosing among these drug therapy options to control motor symptoms in people with early-stage Parkinson’s disease while minimizing negative side effects.

Dopamine-Like Medication

The most common and effective treatment of motor symptoms related to Parkinson’s disease is a combination of the drugs levodopa and carbidopa, sold under the names Duopa, Rytary, and Sinemet.

Sometimes referred to simply as levodopa, or L-DOPA, the drug eventually becomes dopamine that your brain can use.

Dopamine can’t be taken directly as a treatment because it’s broken down in the body before it reaches the brain.

According to these guidelines, levodopa is superior to dopamine agonists (see below) for managing motor symptoms early in the disease. However, it’s also more likely to cause dyskinesia, a type of uncontrolled, involuntary movement that can include fidgeting, writhing, head bobbing, and body swaying.

 To minimize the risk of dyskinesia, doctors are advised to prescribe the lowest effective dose of levodopa and to monitor patients for dyskinesia and other drug side effects over time.

Other possible side effects of levodopa include nausea, vomiting, sleepiness, and orthostatic hypotension, or low blood pressure that occurs when standing up after sitting or sitting up after lying down.

The practice guidelines note that in early Parkinson’s, taking levodopa with meals may decrease nausea, but in later stages of the disease, doing so may decrease the drug’s therapeutic efficacy due to food competing with levodopa for absorption from the gut.

People who use levodopa sometimes experience “wearing off” or “off episodes,” in which motor symptoms occur between medication doses, or even mid-dose. Off episodes can come on gradually or suddenly.

Certain drug treatments have been developed specifically to treat off episodes. These include Inbrija, an orally inhaled form of levodopa, and istradefylline (Nourianz), a medication taken alongside levodopa.

Stopping levodopa abruptly can cause unpleasant withdrawal symptoms, including fever, rigid muscles, unusual body movements, and confusion.

 For this reason, you should never change your dose of levodopa or stop taking it suddenly without first talking to your doctor.

Dopamine Agonists

These medications mimic the action of dopamine in the brain and can have side effects similar to those of levodopa. They may be taken alone or with levodopa.

In rare cases, these medications may cause an uncontrollable desire to gamble, shop, or have sex, collectively known as impulse control disorders.

According to the aforementioned guidelines for treating early Parkinson’s, dopamine agonists are more likely than levodopa to cause impulse control disorders, excessive daytime sleepiness, and sleep attacks. They may also be more likely to cause hallucinations. And, like levodopa, they can contribute to orthostatic hypotension.

Still, individual characteristics such as body size, sex, and disease severity also influence the likelihood of experiencing certain drug side effects, which is why people who are in the early stages of Parkinson’s disease should talk with their doctor about the potential benefits and risks of these medications before starting any of them.

RELATED: When Parkinson’s Treatments Lead to Gambling, Shopping, or Hypersexuality

MAO-B Inhibitors

These medications, which include rasagiline (Azilect) and selegiline (Emsam), inhibit the action of the enzyme monoamine oxidase B (MAO-B), which breaks down dopamine in the brain. This means that more dopamine stays intact for your brain to use.

Sometimes, an MAO-B inhibitor is taken with levodopa to prolong the effect of that drug.

However, taking these drugs at the same time as certain antidepressants and sedatives should be avoided or monitored closely by your doctor because of potentially dangerous interactions.

Common side effects of MAO-B inhibitors include mild nausea, dry mouth, lightheadedness, and constipation.

The practice guidelines note that MAO-B inhibitors are less effective than levodopa at improving mobility in early Parkinson’s and are additionally associated with a higher risk of drug discontinuation because of side effects.

Your doctor can help you decide whether this kind of medication is a good choice for you.

COMT Inhibitors

This group of drugs includes entacapone (Comtan), opicapone (Ongentys), and tolcapone (Tasmar).

These medications inhibit the action of another enzyme that breaks down dopamine in the brain, catechol-O-methyltransferase (COMT). Taken with levodopa, they prolong the drug’s effect. They may be prescribed if a person is experiencing “wearing off” between doses of levodopa.

The most common side effect of COMT inhibitors is diarrhea. They may also cause sleep disturbances, dizziness, or hallucinations.

Tasmar has been shown to cause severe liver disease in some people, so you may need to undergo regular blood tests to assess your liver function if you take it.

Amantadine (Symmetrel)

Amantadine (Symmetrel) is an antiviral medication that may increase the effects of dopamine in the brain. Researchers are unsure why amantadine helps in this area.

Amantadine is sometimes taken by itself early in the course of Parkinson’s disease. It may also be taken later on to help with dyskinesia caused by levodopa.

[ad_2]

Related Articles

Leave a Reply

Back to top button